CRIS Current Research Information System

GIORDANI, BARBARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.726
NA - Nord America 4.669
EU - Europa 4.051
AF - Africa 330
SA - Sud America 228
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 1
Totale 14.021
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.549
IT - Italia 1.777
CN - Cina 1.290
SG - Singapore 1.223
VN - Vietnam 1.020
GB - Regno Unito 591
DE - Germania 403
HK - Hong Kong 384
SE - Svezia 240
IN - India 208
FR - Francia 201
BR - Brasile 173
NL - Olanda 169
KR - Corea 154
RU - Federazione Russa 143
BD - Bangladesh 103
CI - Costa d'Avorio 102
IE - Irlanda 98
FI - Finlandia 92
CA - Canada 79
UA - Ucraina 76
ZA - Sudafrica 71
JP - Giappone 68
TG - Togo 59
ID - Indonesia 44
CH - Svizzera 40
SC - Seychelles 35
BE - Belgio 34
TH - Thailandia 32
EE - Estonia 31
JO - Giordania 28
AR - Argentina 27
BG - Bulgaria 26
ES - Italia 24
PH - Filippine 22
TR - Turchia 22
NG - Nigeria 21
IQ - Iraq 19
PL - Polonia 19
IR - Iran 18
PK - Pakistan 18
AT - Austria 17
MX - Messico 17
TW - Taiwan 15
AU - Australia 12
MY - Malesia 11
UZ - Uzbekistan 10
CZ - Repubblica Ceca 9
EG - Egitto 9
GR - Grecia 9
HR - Croazia 9
NO - Norvegia 9
EC - Ecuador 8
TN - Tunisia 8
CL - Cile 7
RO - Romania 6
SA - Arabia Saudita 6
DK - Danimarca 5
DZ - Algeria 5
IL - Israele 5
KE - Kenya 5
LB - Libano 5
BB - Barbados 4
CO - Colombia 4
MA - Marocco 4
NZ - Nuova Zelanda 4
OM - Oman 4
SI - Slovenia 4
AL - Albania 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
KZ - Kazakistan 3
PE - Perù 3
PR - Porto Rico 3
SN - Senegal 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BZ - Belize 2
ET - Etiopia 2
GT - Guatemala 2
KW - Kuwait 2
LT - Lituania 2
NP - Nepal 2
PA - Panama 2
PS - Palestinian Territory 2
PT - Portogallo 2
QA - Qatar 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
VE - Venezuela 2
AM - Armenia 1
AO - Angola 1
BW - Botswana 1
BY - Bielorussia 1
CM - Camerun 1
CU - Cuba 1
CV - Capo Verde 1
Totale 14.009
Salva come PNG Salva come JPEG
Città #
Singapore 828
Ashburn 559
Southend 465
Hong Kong 351
San Jose 335
Bologna 331
Hefei 302
Chandler 245
Ho Chi Minh City 225
Hanoi 221
Dallas 204
Santa Clara 175
Ann Arbor 167
Los Angeles 151
New York 145
Seoul 141
Beijing 130
Frankfurt am Main 126
Fairfield 117
Boardman 109
Abidjan 102
Princeton 102
Milan 100
Dong Ket 97
Dublin 95
Council Bluffs 94
Houston 88
Seattle 83
Wilmington 82
Rome 69
Helsinki 64
Lauterbourg 64
Lomé 59
Turin 54
Woodbridge 53
Cambridge 52
Nanjing 49
Padova 48
Tokyo 47
Berlin 42
Redmond 42
Shanghai 42
Westminster 42
Buffalo 41
Guangzhou 40
San Francisco 35
Medford 33
Orem 33
Dearborn 32
Tukwila 32
Denver 30
Haiphong 30
Naples 30
Bengaluru 29
Chicago 29
Da Nang 29
Munich 29
Amman 28
Atlanta 28
Jinan 28
Montreal 27
São Paulo 26
London 25
Redondo Beach 25
Sofia 25
Toronto 25
Basingstoke 24
Brooklyn 24
Jakarta 24
Tianjin 24
Bern 22
Phoenix 22
Shenyang 22
Abeokuta 21
Brussels 21
Florence 21
Johannesburg 20
Redwood City 20
Rimini 20
The Dalles 20
Nanchang 19
Changsha 18
Catania 17
Genoa 17
Saint Petersburg 17
Zhengzhou 17
Cesena 16
Modena 16
Biên Hòa 15
Boston 15
Verona 15
Amsterdam 14
Bangkok 14
Forlì 14
Lappeenranta 14
Cagliari 13
Des Moines 12
Hebei 12
Falkenstein 11
Nuremberg 11
Totale 8.188
Salva come PNG Salva come JPEG
Nome #
Accuratezza della spettrometria di massa MALDI-TOF nell’identificazione di specie di lattobacilli 743
Lactobacillus Biofilms Influence Anti-Candida Activity 734
NUOVI APPROCCI PER L’IDENTIFICAZIONE DI SPECIE DI LATTOBACILLI: RUOLO DELLA SPETTROMETRIA DI MASSA MALDI-TOF E DELLA METABOLOMICA 495
BIFIDOBACTERIUM BREVE BC104: ORALLY ADMINISTERED VAGINAL PROBIOTIC FOR PREVENTING GENITAL AND URINARY TRACT INFECTIONS 410
Lactobacillus crispatus BC5 Interferes With Chlamydia trachomatis Infectivity Through Integrin Modulation in Cervical Cells. 289
Insights Into Vaginal Bacterial Communities and Metabolic Profiles of Chlamydia trachomatis Infection: Positioning Between Eubiosis and Dysbiosis 283
Antioxidant and Functional Features of Pre-Fermented Ingredients Obtained by the Fermentation of Milling By-Products 258
Biosurfactant from vaginal Lactobacillus crispatus BC1 as a promising agent to interfere with Candida adhesion 249
Vaginal Lactobacilli Supernatants Protect from Herpes Simplex Virus Type 1 Infection in Cell Culture Models 236
Vaginal Lactobacillus gasseri biosurfactant: a novel bio- and eco-compatible anti-Candida agent 226
Lactobacilli extracellular vesicles: potential postbiotics to support the vaginal microbiota homeostasis 223
Design and validation of a DNA-microarray for phylogenetic analysis of bacterial communities in different oral samples and dental implants 221
Liposomes containing biosurfactants isolated from Lactobacillus gasseri exert antibiofilm activity against methicillin resistant Staphylococcus aureus strains 218
Exopolysaccharides from vaginal lactobacilli modulate microbial biofilms 217
Anti-bacterial activity of vaginal lactobacilli against Chlamydia trachomatis 212
Biosurfactant for solubilization and skin permeation enhancement of hydrocortisone 212
Lactobacilli cell-free supernatants: Potential green and natural enhancers for nose-to-brain delivery of small hydrophilic molecules 202
Novel approaches for the taxonomic and metabolic characterization of lactobacilli: Integration of 16S rRNA gene sequencing with MALDI-TOF MS and 1H-NMR 202
Biotechnological Valorization of Brewer's Spent Grains and Grape Pomace to Obtain Functional Ingredients for Food Formulations 200
Novel mixed vesicles containing lactobacilli biosurfactants for vaginal delivery of econazole nitrate 199
OralArray: a new phylogenetic DNA-microarray to characterize the oral microbiota 196
Vaginal Lactobacillus strains interfere with Chlamydia trachomatis infection 188
Vaginal Lactobacillus Impair Candida Dimorphic Switching and Biofilm Formation 185
Studio in vitro dell’attività antimicrobica di lattobacilli vaginali nei confronti di Chlamydia trachomatis. 183
Protective Mechanisms of Vaginal Lactobacilli against Sexually Transmitted Viral Infections 182
Association of mucoadhesive polymeric matrices and liposomes for local delivery of miconazole: A new approach for the treatment of oral candidiasis 179
Lecithin and Chitosan as Building Blocks in Anti-Candida Clotrimazole Nanoparticles 178
Limosilactobacillus vaginalis Exerts Bifidogenic Effects: A Novel Postbiotic Strategy for Infant Prebiotic Supplementation 173
Dairy bioactives and functional ingredients with skin health benefits 173
Anti-candida activity of hyaluronic acid combined with lactobacillus crispatus lyophilised supernatant: A new antifungal strategy 173
Approcci innovativi per l’identificazione di specie di lattobacilli: studio dei metaboliti mediante spettrometria di risonanza magnetica (1H-RMN) 171
Isolation and characterization of biosurfactants produced by Lactobacillus gasseri of vaginal origin 167
Biosurfactant loaded vesicles for the local treatment of Staphylococcus aureus skin infections 167
Orange Peel Lactiplantibacillus plantarum: Development of A Mucoadhesive Nasal Spray with Antimicrobial and Anti-Inflammatory Activity 165
Ondansetron Buccal Administration for Paediatric Use: A Comparison Between Films and Wafers 164
Mucoadhesive and mucopenetrating chitosan nanoparticles for glycopeptide antibiotic administration 161
Functional and biochemical characterization of pre-fermented ingredients obtained by the fermentation of durum wheat by-products 158
Lactobacillus crispatus BC1 Biosurfactant Delivered by Hyalurosomes: An Advanced Strategy to Counteract Candida Biofilm 156
Vaginal Bifidobacterium breve for preventing urogenital infections: Development of delayed release mucoadhesive oral tablets 154
Development and validation of a new phylogenetic DNA-microarray specific for the oral microbiota 146
Freeze-Dried Matrices Based on Polyanion Polymers for Chlorhexidine Local Release in the Buccal and Vaginal Cavities 145
Interaction of vaginal Lactobacillus strains with HeLa cell plasma membrane. 144
THE HEALTH-PROMOTING EFFECT OF EXTRACELLULAR VESICLES RELEASED BY VAGINAL LACTOBACILLI 143
Utilizing liposomal quercetin and gallic acid in localized treatment of vaginal Candida infections 142
The vaginal microbiome of healthy, bacterial vaginosis and Chlamydia trachomatis-infected women 141
Prebiotic Activity of Vaginal Lactobacilli on Bifidobacteria: from Concept to Formulation 141
Lactobacillus strains isolated from vaginal microbiota of healthy women inhibit Candida growth and adherence 137
Lactobacillus crispatus BC1 Biosurfactant Counteracts the Infectivity of Chlamydia trachomatis Elementary Bodies 136
Effect of Lactobacillus biosurfactant on hydrocortisone solubilization and skin permeation 135
New Spanish Broom dressings based on Vitamin E and Lactobacillus plantarum for superficial skin wounds 135
Role of vaginal lactobacilli in counteracting Chlamydia trachomatis infectivity in an in vitro model 134
Lactobacilli cell-free supernatants can improve cromolyn nasal absorption 133
Novel approaches for the species-level identification of lactobacilli: integration of 16S rRNA gene sequencing with MALDI-TOF MS and 1H-NMR 132
Influence of lactobacillus biosurfactants on skin permeation of hydrocortisone 132
Characterization of anti-Candida activity of vaginal lactobacilli 127
Biosurfactant-based mixed vesicles for vaginal delivery of econazole 123
Interaction of vaginal Lactobacillus strains with HeLa cells plasma membrane 122
Development of chitosan nanoparticles with mucoadhesive/mucopenetrating properties 117
Preliminary results on the preparation of Spanish Broom, flax and hemp wound dressings based on 18-β-glycyrrhetinic acid-cyclodextrin inclusion complexes 116
Orally administered vaginal Bifidobacterium Breve BC104 for preventing genital and urinary tract infections 113
A new wound dressing based on Spanish Broom fibers for the local release of Vitamin E and Lactobacillus plantarum 113
Vaginal lactobacilli exert prebioTIc effects towards gut bifidobacteria 108
Human Lactobacillus Biosurfactants as Natural Excipients for Nasal Drug Delivery of Hydrocortisone 108
New liposomes containing natural molecules for treatment of vaginal diseases 106
Functional and Safety Profile of Limosilactobacillus vaginalis and Development of Oral Fast-Disintegrating Tablets for Gut Microbiota Modulation 105
Freeze-dried matrices for chlorhexidine release in the buccal and vaginal cavities 105
Exopolysaccharides released by vaginal Lactobacillus strains: chemical characterization and modulation of biofilm formation. 103
Impact of Lactobacillus exopolysaccharides on vaginal microbial biofilms 100
Lactobacillus biosurfactant as natural excipient for nasal drug delivery 99
null 96
null 94
New Spanish Broom’s wound dressing loaded with Vitamin E and Lactobacillus plantarum for skin wounds 92
Lactobacillus biosurfactant: a green excipient for the preparation of vaginal mixed vesicles 91
Novel mixed vesicles containing lactobacilli biosurfactant for vaginal delivery of an anti-Candida agent 89
Sistemi gelificanti in situ per la veicolazione intranasale e naso-cervello di farmaci con diverse proprietà fisico-chimiche 88
Vaginal Lactobacilli interfere with Chlamydia trachomatis infection process in HeLa cells. 86
Candida spp. biofilm formation is inhibited by vaginal Lactobacillus supernatants 82
LACTOBACILLUS VAGINALIS BC17 DERIVATIVES EXERT BIFIDOGENIC ACTIVITY 79
The vaginal microbiome of healthy, bacterial vaginosis and Chlamydia trachomatis-infected women 79
Tailored anti-biofilm activity - Liposomal delivery for mimic of small antimicrobial peptide 76
Lactobacilli as Anti-biofilm Strategy in Oral Infectious Diseases: A Mini-Review 75
Liposomes-in-chitosan hydrogel boosts potential of chlorhexidine in biofilm eradication in vitro 71
Nanocarriers for the delivery of Lactobacillus crispatus BC1 biosurfactant: alternative strategies to fight Candida biofilms 58
Biotechnological valorization of brewer's spent grains through microbial fermentation and High-Pressure Homogenization (HPH) treatments to obtain functional ingredients for food formulations 56
Microbial fermentation and high-pressure homogenization as integrated strategies for the valorization of brewer’s spent grains into functional food ingredients 52
null 47
Totale 14.354
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.915
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.915
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021265 0 0 0 0 0 0 0 0 0 0 0 265
2021/20221.022 83 57 55 27 103 57 39 75 46 82 215 183
2022/20231.483 137 185 79 177 111 106 29 87 256 104 105 107
2023/2024911 57 73 64 98 92 174 60 72 42 64 59 56
2024/20252.543 122 228 237 186 318 120 316 146 62 164 193 451
2025/20266.255 429 595 527 430 474 257 817 184 887 436 935 284
Totale 14.354